Clinical activity and safety of antiprogrammed death-1 (PD-1) (BMS-936558/MDX-1106/ONO-4538) in patients (pts) with previously treated, metastatic renal cell carcinoma (mRCC): An updated analysis.
暂无分享,去创建一个
David C. Smith | T. Choueiri | M. Atkins | C. Drake | M. Sznol | J. Wigginton | A. Gupta | G. Kollia | J. Powderly